MFAEs could significantly alleviate liver fibrosis and significantly reduced the distribution of alpha-smooth muscle actin (α-SMA) protein in liver tissue and HA and HYP level in serum (P < 0.01) (Fig. 5A and B). Here, ACTA1 is linked to Hepatic fibrosis.